Correlation Between Amarin PLC and Sucampo Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amarin PLC and Sucampo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amarin PLC and Sucampo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amarin PLC and Sucampo Pharmaceuticals, you can compare the effects of market volatilities on Amarin PLC and Sucampo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amarin PLC with a short position of Sucampo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amarin PLC and Sucampo Pharmaceuticals.

Diversification Opportunities for Amarin PLC and Sucampo Pharmaceuticals

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Amarin and Sucampo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Amarin PLC and Sucampo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sucampo Pharmaceuticals and Amarin PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amarin PLC are associated (or correlated) with Sucampo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sucampo Pharmaceuticals has no effect on the direction of Amarin PLC i.e., Amarin PLC and Sucampo Pharmaceuticals go up and down completely randomly.

Pair Corralation between Amarin PLC and Sucampo Pharmaceuticals

If you would invest (100.00) in Sucampo Pharmaceuticals on January 25, 2024 and sell it today you would earn a total of  100.00  from holding Sucampo Pharmaceuticals or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Amarin PLC  vs.  Sucampo Pharmaceuticals

 Performance 
       Timeline  
Amarin PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amarin PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in May 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Sucampo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sucampo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Sucampo Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Amarin PLC and Sucampo Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amarin PLC and Sucampo Pharmaceuticals

The main advantage of trading using opposite Amarin PLC and Sucampo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amarin PLC position performs unexpectedly, Sucampo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sucampo Pharmaceuticals will offset losses from the drop in Sucampo Pharmaceuticals' long position.
The idea behind Amarin PLC and Sucampo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance